SCHEMBL6982378

SCHEMBL6982378

CC(C)C1(C(=O)O)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CYP2D6 P10635 1/20 0.38
AKR1C1 Q04828 1/20 0.37
OPRM1 P35372 2/20 0.36
OPRL1 P41146 1/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 1/20 0.34
CYP2C9 P11712 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SLC6A2 P23975 2/20 0.33
TSHR P16473 1/20 0.33
ALOX15 P16050 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981459 0.81 OPRM1 (0.46) SMN1; SMN2OPRM1MEN1KMT2AL3MBTL1
SCHEMBL6982070 0.77 AKR1C1 (0.40) ALDH1A1AKR1C1OPRM1OPRL1LMNA
SCHEMBL6981777 0.75 AKR1C1 (0.41) ALDH1A1SMN1; SMN2AKR1C1OPRM1OPRL1
SCHEMBL6978477 0.71 LMNA (0.39) SMN1; SMN2AKR1C1OPRM1OPRL1LMNA
SCHEMBL6979914 0.69 MEN1 (0.51) OPRM1OPRL1LMNAMEN1KMT2A
SCHEMBL6971207 0.68 OPRM1 (0.44) ALDH1A1SMN1; SMN2OPRM1OPRL1KMT2A
SCHEMBL6967893 0.68 CNR1 (0.40) ALDH1A1AKR1C1KMT2AL3MBTL1MAPK1
SCHEMBL6982594 0.68 HSD11B1 (0.39) SMN1; SMN2AKR1C1MEN1CYP2C9KMT2A
SCHEMBL6982390 0.67 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2AKR1C1OPRM1OPRL1
SCHEMBL11185358 0.67 ALDH1A1 (0.57) ALDH1A1AKR1C1OPRM1OPRL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed